Planned sale

Colgate-Palmolive (CL): Officer filed to sell ~$2.01M

Wallace Noel R., Officer at Colgate-Palmolive, filed to sell ~$2.01M of Colgate-Palmolive shares.

~$2.01M
planned to sell · 20K shares, around Nov 5, 2026
Planned for
Nov 5, 2026
Notice filed
Nov 5, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 27, 2026CongressDisclosed partial sale of CL — reported range $1,001 - $15,000
  2. Aug 31, 2026CongressDisclosed sale of CL — reported range $1,001 - $15,000
  3. Sep 2, 2026CongressDisclosed partial sale of CL — reported range $1,001 - $15,000
  4. Oct 30, 2026Company filing · Form 8-K · ResultsReported its results
  5. Nov 4, 2026Insider · 2 peopleInsiders: 2 sales (~$4.3M)
  6. Nov 5, 2026Insider · 2 peopleInsiders: 2 sales (~$2.4M)

What came next

  1. Nov 10, 2026InsiderOfficer sold ~$402K of CL shares in the open market
View the official recordSEC Form 144

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Colgate-Palmolive

For Colgate-Palmolive, OQRO holds 10 insider filings (SEC Form 4 or Form 144) and 4 Congress trade reports dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CL page.

How this filing works

Explore the data

Other disclosures at Colgate-Palmolive

Everything OQRO holds on this company is on its CL page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data